Thank you, David. Good morning, everyone. On Slide 6, net sales in the first quarter were $220.3 million, up 6.5% from the prior year period on a constant currency basis and within the guidance we provided last quarter. As we have discussed for the past year, ongoing supply chain challenges continue to impact our ability to meet customer demand. This challenge resulted in an estimated $25 million of delayed shipments in the first quarter, about $10 million higher than we have been experiencing; but, on a relative basis, about the same percentage of total backlog. The shortages are primarily in drives and controls and motors with drives and controls directly impacted by the chip shortages. Looking at our sales bridge, pricing was a major driver of our growth, up $9.6 million or 4.5%. The Garvey acquisition added $8.5 million of growth. We did see volumes decline 2%, or $4.3 million. While the demand is there, as I noted, we are still constrained by material shortages, preventing us from getting more volume out the door. The decline in volume can also be attributed to the ERP implementation at our largest operation in Germany that we discussed on the last call. This impacted volume in the quarter about $11 million, or 5%, as the team worked through the learning curve of a new ERP system. The environment is now stable, and this should not be a headwind, going forward. Foreign currency was a headwind that reduced sales by $7 million, or 3.3% of sales. Let me provide a little color on sales by region. For the first quarter, the U.S. improved pricing by 5.1%. Sales volumes were flat for the reasons I noted earlier. Outside of the U.S., pricing improved by 3.6%. Sales volume was down approximately 5% as volume decreased approximately 8% in Europe, primarily due to the ERP implementation and 15% in APAC due to the impact that the pandemic is having in that region of the world. Offsetting these declines were volume increases of 21% in Latin America and 5% in Canada. As David stated earlier, our order rates remain robust and annualize to over $1 billion level. We have record backlog and expect that, when supply chains improve, we will see even stronger top line growth. On Slide 7, we achieved record gross margin of 37.5%. This was up 280 basis points from the prior year. On an adjusted basis, gross margin was higher by 120 basis points as we benefited from incremental pricing, a favorable mix, and favorable one-time inventory adjustments, which more than offset the negative impact on absorption from the ERP system implementation in Germany. Overall, our precision conveyance businesses were 100 basis points accretive to our adjusted gross margin this quarter. Let me point out a few highlights on our gross profit bridge. First quarter gross profit increased $8.5 million compared with the prior year and was driven by several factors. The Garvey acquisition provided $3.1 million of gross profit. Pricing net of material inflation added $3.1 million of gross profit, as we have successfully passed through material inflation increases. Favorable mix added $1 million. In the prior year quarter, we also had $3.5 million of acquisition inventory step-up expense and integration costs associated with the Dorner acquisition, which did not repeat. Foreign currency translation reduced gross profit by $2.5 million. As shown on Slide 8, RSG&A costs were $53.2 million in the quarter, or 24.1% of sales. RSG&A expense included $1.7 million of business realignment costs and were $51.4 million excluding these costs. This was lower than the guidance given last quarter, principally due to lower stock compensation expense as equity prices declined throughout the quarter, and we adjusted our FY '21 LTIP grant to its expected performance payout. Compared with the prior year, RSG&A costs were lower by $4 million. This was due to $8.7 million of acquisition and deal and integration costs incurred in the prior year related to the Dorner acquisition. While foreign currency translation lowered our RSG&A cost by $1.6 million, $1.4 million of incremental RSG&A costs were incurred related to the Garvey acquisition. For the fiscal second quarter, we expect RSG&A expense to range between $54 million and $55 million, which reflects the timing of our July 1 merit increases, offset by measures we are taking to control costs. Turning to Slide 9. Operating income in the quarter was $22.8 million, and adjusted operating income was $24.6 million. Adjusted operating margin was 11.1% of sales, equivalent to the prior year and down slightly from the trailing quarter as we had less scale for RSG&A costs as a percent of sales due to the lower sequential sales volumes. As you can see on Slide 10, we recorded GAAP earnings per diluted share for the quarter of $0.29. Our tax rate on a GAAP basis was 52% in the quarter. This reflects two discrete items that increased the tax rate by 27 points. The rate was unfavorably impacted 15 points due to a settlement for income tax assessments related to tax periods prior to our acquisition of STAHL. In accordance with the tax indemnification clause of the share purchase agreement, we received full reimbursement from STAHL's prior owner, which was recorded as a gain in other income during the quarter. The tax rate was also unfavorably impacted by 12 points due to the recording of a U.S. state tax valuation allowance. For the full year, the tax rate is expected to be between 29% and 30% with these discrete items. Adjusted earnings per diluted share of $0.69 was equivalent to the prior year period. As a reminder, we add back amortization expense on a tax-affected basis to our adjusted earnings per diluted share calculation. With rising interest rates, interest expense is expected to increase to $6.8 million in the second quarter. Weighted average diluted shares outstanding were approximately 29 million, and we will continue to use 22% as our pro forma tax rate when calculating non-GAAP adjusted earnings per share. On Slide 11, our adjusted EBITDA margin for the quarter was 15.9%, and our trailing 12-month EBITDA margin was 15.4%. The Garvey acquisition was accretive to our adjusted EBITDA margin in the quarter by 20 basis points. Our trailing 12-month return on invested capital was 6.8%. We are targeting $1.5 billion in revenue with a 21% EBITDA margin as covered at our recent Investor Day. We have a detailed plan to achieve these objectives over the next five years and have been executing our strategy to drive long-term shareholder value. Moving to Slide 12. We had negative free cash flow of approximately $14 million in the first quarter. This includes cash outflows from operating activities of $11 million and CapEx of $3 million. The negative free cash flow was anticipated and reflects the timing of our annual bonus payments for fiscal year '22 as well as incremental investments in inventory to meet future demand and lessen supply chain impacts. We expect capital expenditures of $25 million to $30 million in fiscal 2023 as we invest in our factories to enable the next leg of our margin expansion initiatives. Turning to Slide 13. We have a strong and flexible capital structure comprised of a term loan B, which requires $5.2 million of required principal payments annually and has an excess cash flow sweep depending on total leverage. We paid down $10 million of debt in the quarter and expect to pay $40 million for the entire fiscal year. The term loan B is 60% hedged with interest rate swaps that blend to a swap rate of approximately 2.08%. As of June 30, on a pro forma basis, which includes Garvey's LTM adjusted EBITDA but excludes expected cost synergies, our net leverage ratio was 2.9x. We have a strong history of delevering after acquisitions and plan to prioritize debt repayment as part of our capital allocation, along with bolt-on acquisitions at a reasonable price. Finally, our liquidity, which includes our cash on hand and revolver availability, remained strong and was approximately $168 million at the end of June. Please advance to Slide 14, and I will turn it back over to David.